Alto Neuroscience, Inc. - ANRO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Perceptive Advisors LLC 9.99% 4,176,711 View
Aug 14, 2026 SCHEDULE 13G/A Joseph Edelman 9.99% 4,176,711 View
Aug 14, 2026 SCHEDULE 13G/A Perceptive Life Sciences Master Fund, Ltd. 9.99% 4,176,711 View
Aug 14, 2026 SCHEDULE 13G/A Vestal Point Capital, LP 2.2% 785,000 View
Aug 14, 2026 SCHEDULE 13G/A Ryan Wilder 2.2% 785,000 View
Aug 14, 2026 SCHEDULE 13G/A Sirenia Capital Management LP 6.2% 2,219,568 View
Aug 14, 2026 SCHEDULE 13G/A Alex Silverstein 6.2% 2,219,568 View
Jul 20, 2026 SCHEDULE 13G EcoR1 Capital, LLC 5.8% 2,232,000 View
Jul 20, 2026 SCHEDULE 13G Oleg Nodelman 5.8% 2,232,000 View
Jul 20, 2026 SCHEDULE 13G EcoR1 Capital Fund Qualified, L.P. 5.3% 2,065,935 View
May 15, 2026 SCHEDULE 13G/A Vestal Point Capital, LP 6.5% 2,064,075 View
May 15, 2026 SCHEDULE 13G/A Ryan Wilder 6.5% 2,064,075 View
May 15, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 1.6% 503,087 View
May 15, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 1.6% 503,087 View
May 15, 2026 SCHEDULE 13G/A Point72 Biotech Private Investments, LLC 2.1% 667,778 View
May 15, 2026 SCHEDULE 13G/A Differentiated Ventures Investments, LLC 2.1% 667,778 View
May 15, 2026 SCHEDULE 13G/A 72 Investment Holdings, LLC 2.1% 667,778 View
May 15, 2026 SCHEDULE 13G/A Steven A. Cohen 3.7% 1,170,865 View
May 15, 2026 SCHEDULE 13G/A Commodore Capital LP 9.9% 3,588,180 View
May 15, 2026 SCHEDULE 13G/A Commodore Capital Master LP 9.9% 3,588,180 View
May 15, 2026 SCHEDULE 13G/A Robert Egen Atkinson 9.9% 3,588,180 View
May 15, 2026 SCHEDULE 13G/A Michael Kramarz 9.9% 3,588,180 View
May 15, 2026 SCHEDULE 13G Sirenia Capital Management LP 7.9% 2,591,587 View
May 15, 2026 SCHEDULE 13G Alex Silverstein 7.9% 2,591,587 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.